GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (LSE:SCLP) » Definitions » Price-to-Free-Cash-Flow

Scancell Holdings (LSE:SCLP) Price-to-Free-Cash-Flow

: N/A (As of Today)
View and export this data going back to 2010. Start your Free Trial

As of today (2024-04-16), Scancell Holdings's share price is £0.0985. Scancell Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 was £-0.01. Hence, Scancell Holdings's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Scancell Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

LSE:SCLP's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.34
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Scancell Holdings's Free Cash Flow per Share for the six months ended in Oct. 2023 was £-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was £-0.01.

During the past 5 years, the average Free Cash Flow per Share Growth Rate was 5.00% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -2.30% per year.

During the past 13 years, Scancell Holdings's highest 3-Year average Free Cash Flow per Share Growth Rate was 54.70% per year. The lowest was -21.60% per year. And the median was 8.00% per year.


Scancell Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for Scancell Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Scancell Holdings Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Biotechnology subindustry, Scancell Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings Price-to-Free-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Price-to-Free-Cash-Flow falls into.



Scancell Holdings Price-to-Free-Cash-Flow Calculation

Scancell Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.0985/-0.013
=N/A

Scancell Holdings's Share Price of today is £0.0985.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Scancell Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 was £-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Scancell Holdings  (LSE:SCLP) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Scancell Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings (LSE:SCLP) Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (LSE:SCLP) Headlines

No Headlines